TrialPath
Parkinson's disease · San Diego

Parkinson's disease clinical trials in San Diego

5 recruiting parkinson disease studies within range of San Diego. Click any trial for full eligibility criteria and contact info.

Blood Pressure Effects on Cognition and Brain Blood Flow in PD

NCT05400174 · Parkinson Disease, Orthostatic Hypotension, Dysautonomia
Recruiting

Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-motor symptoms, such as problems thinking and orthostatic hypotension (OH), i.e., low blood pressure (BP) when standing. About one-third of people with PD have OH, which can cause sudden, temporary symptoms while upright, including lightheadedness, dizziness, and fainting. People with PD and OH can also experience problems thinking that happen only while upright and not while sitting - this can occur without other symptoms, such as feeling dizzy or faint. However, the level of low BP that can affect thinking remains unknown, and no guidelines exist for treating OH when it happens without symptoms. This is significant because OH could be a treatable risk factor for thinking problems in PD, but OH is often not treated if people do not report obvious symptoms. This project's goal is to determine how BP affects brain function in PD. The proposed experiments will measure BP and brain blood flow continuously in real-time using innovative wearable technology. Persons with PD with OH and without OH will undergo repeated cognitive tests while supine (lying down) and while upright. I will study the associations between BP, thinking abilities, and brain blood flow, and will compare groups with and without OH. These findings could be important because if a certain level of BP correlates with thinking abilities, then treating OH in PD may prevent thinking problems, which would improve health-related quality of life and reduce disability and healthcare costs.

PhaseNA
TypeInterventional
Age50 Years
WhereSan Diego, California, United States
SponsorUniversity of California, San Diego
Tap for details
Apply

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

NCT04477785 · Parkinson Disease
Recruiting

The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.

Phase
TypeObservational
Age30 Years
WhereBirmingham, Alabama, United States + 49 more
SponsorMichael J. Fox Foundation for Parkinson's Research
Tap for details
Apply

Real-Time Levodopa Level Monitoring in Parkinson Disease

NCT04735627 · Parkinson Disease
Recruiting

This project aims to develop a minimally invasive sensor device to monitor levodopa levels in real time. We will test the accuracy, tolerability, and safety of this device in people with Parkinson disease.

PhaseNA
TypeInterventional
Age40 Years – 85 Years
WhereSan Diego, California, United States
SponsorUniversity of California, San Diego
Tap for details
Apply

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

NCT06482268 · PD - Parkinson's Disease
Recruiting

To evaluate the safety and efficacy of transplantation of human induced pluripotent stem cell-derived dopaminergic progenitors, CT1-DAP001, into the corpus striatum in patients with Parkinson's disease

PhasePhase 1
TypeInterventional
Age40 Years – 75 Years
WhereLa Jolla, California, United States
SponsorUniversity of California, San Diego
Tap for details
Apply

Parkinson's Foundation PD GENEration Genetic Registry

NCT04994015 · Parkinson's Disease
Recruiting

Development of a central repository for PD-related genomic data for future research.

Phase
TypeObservational
Age18 Years
WhereBirmingham, Alabama, United States + 55 more
SponsorParkinson's Foundation
Tap for details
Apply